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Our knowledge of the autonomic nervous system has
increased with an understanding of heart rate variability
(HRV), a non-invasive measure of cardiac autonomic
control (Pagani et al. 1986; Task Force of the European
Society of Cardiology and the North American Society of
Pacing and Electrophysiology, 1996). Two main frequency
components of HRV have been demonstrated, low
frequency (LF, 0.04–0.15 Hz) reflecting the interaction of
both the sympathetic and parasympathetic (vagal) nervous
systems, and high frequency (HF, > 0.15 Hz) reflecting
solely the activity of the parasympathetic nervous system
(Pagani et al. 1986; Task Force of the European Society of
Cardiology and the North American Society of Pacing and
Electrophysiology, 1996). The most prominent aspect of
this new measure (HRV) has been its use as a predictor of
mortality in patients with cardiovascular disease (Kleiger et
al. 1987) and in the general population (Tsuji et al. 1996).
Tsuji and colleagues (1996), who were part of the
Framingham Heart Study, reported that low HRV
measures were significantly associated with the risk of
cardiac events in healthy adults examined regularly over a
36 year period.
The extent to which HRV is influenced by the sex of the
subject has been contentious, with studies reporting
significantly greater (Gregoire et al. 1996; Huikuri et al.
1996), significantly lower (Bigger et al. 1995; Sinnreich et
al. 1998) or similar (Stein et al. 1997; Yeragani et al. 1997)
HRV for females compared to males. To our knowledge,
studies examining HRV differences between the sexes have
not considered the menstrual cycle phase at which HRV
recordings were obtained for females. Discrepancies in
studies reporting male/female differences in HRV may be a
result of the time of the menstrual cycle for females at
which the HRV comparison was made with males. Sato et
al. (1995) reported greater sympathetic activity (LF/HF)
during mental challenge in the luteal phase compared with
the follicular phase. Others have reported autonomic
changes during the normal menstrual cycle (Saeki et al.
1997; Ettinger et al. 1998). Saeki et al. (1997) reported
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significantly greater parasympathetic activity during the
follicular phase compared to other phases of the ovarian
cycle in healthy women and concluded that para-
sympathetic activity appeared to be influenced by
oestrogen while sympathetic activity was modulated by
progesterone. The relationship between endogenous
female sex hormones, HRV and the autonomic nervous
system still remains to be clarified. Therefore, the aim of
the current study was to elucidate further the association
between HRV and endogenous female sex hormone
fluctuations during the menstrual cycle and its possible
contribution to male/female differences in HRV.
As previously stated, cardiac autonomic fluctuations have
been reported at various times during the menstrual cycle.
However, there have been few studies to examine any
possible association between HRV and the endogenous
levels of pituitary gonadotrophins, luteinising hormone
(LH) and follicle-stimulating hormone (FSH), or their
interaction with oestrogen and progesterone during the
menstrual cycle. Therefore, in the current study we
examined the relationship between HRV and the four
endogenous sex hormones at times of low and high
hormonal influence. It was theorised that HRV fluctuations
during the menstrual cycle may result from endogenous
female sex hormone interactions. Further, it was
hypothesised that if a relationship between oestrogen levels
and parasympathetic activity existed, then HRV would
exhibit cyclic variations in synchrony with oestrogen levels.
Such a relationship would further clarify the mechanism
for the reported cardioprotective effects of oestrogen
(Mercuro et al. 2000; Saleh et al. 2000).
METHODS 
Subjects
Ten healthy female subjects with a mean (± S.E.M.) age of
24.7 ± 2.4 years and body mass of 63.8 ± 3.9 kg volunteered for
this study. Subjects had not exercised regularly for at least
3 months prior to commencement of the study and all completed
questionnaires to confirm their healthy status. Subjects were not
taking any medications including oestrogen/progesterone
contraceptives and all were confirmed as non-smokers. All subjects
had regular menstrual cycles prior to HRV determination as
indicated by 3 months of daily supine basal temperature recordings
using an oral digital thermometer (Becton Dickinson, Ontario,
Canada). Each subject was familiarised with the testing equipment
and procedures used in the laboratory and then provided written
informed consent prior to participation. The study was approved
by the University of Southern Queensland Human Ethics
Committee.
Protocol
Subjects reported to the laboratory at each of the following
phases of the menstrual cycle: menses (day 3.8 ± 0.5; range, 1–5);
ovulation (day 15.8 ± 0.7; range, 11–21) and luteal (day 22.1 ± 0.4;
range, 21–24). These phases were based upon the cyclic
variations in gonadotrophic and ovarian hormone levels during
the menstrual cycle (Guyton & Hall, 2000) and were utilised to
ensure that HRV recordings were obtained at times of low
(menses) and high (ovulation and luteal) hormonal influence.
Recordings of the onset of menstrual bleeding and daily supine
basal temperature enabled each subject to identify each
menstrual cycle phase for HRV determination. For each
menstrual cycle phase, subjects arrived at the laboratory (room
temperature 20–24 °C) at the same time of day between 06.00
and 12.00 h, 12 h post-prandial (Widerlov et al. 1999) and at
least 24–36 h post-exercise (Furlan et al. 1993). Body mass was
recorded and skin was prepared for the application of heart rate
monitoring electrodes (3M Australia Pty Ltd, Brisbane). A
Marquette Holter monitor 8500 (Marquette Electronics Inc.,
Milwaukee, WI, USA) was connected to the electrodes using
modified V1 and V5 leads to record HR. Each subject rested in the
supine position for 40 min, and resting HRV was determined
during the final 20 min. An initial 20 min period was utilised to
ensure the attainment and stabilisation of resting HR.
Throughout the resting period subjects lay awake on a bench in
a quiet environment with minimal noise and body movement.
Breathing rate and depth were spontaneous for all subjects and
not controlled as prior studies have demonstrated that controlled
(metronome) breathing was a stressor and altered HR (Patwardhan
et al. 1995). Recently, others have demonstrated minimal
changes in HRV and vagal modulations during spontaneous and
controlled breathing over the typical resting breathing rates
(Bloomfield et al. 2001; Patwardhan et al. 2001). At the
completion of the heart rate recording and with the subject free
of all testing equipment, 10 ml of blood was removed by
antecubital venipuncture. Blood was allowed to clot normally
and then centrifuged with the serum removed and stored at
_80 °C for later analysis. Serum LH, FSH, oestrogen (17b-
oestradiol) and progesterone levels were determined by an
independent laboratory using a Ciba Corning Automated
Chemiluminescence System 180 or microparticle enzyme
immunoassay. 
Data and statistical analysis
Heart rate (HR) recordings were analysed for HRV on a
commercially available Holter analysis system (Marquette series
8000). Frequency domain measurements of HRV were determined
by spectral analysis using fast Fourier transformation (FFT) as
previously described (Leicht et al. 2003). Briefly, R–R intervals
over a 2 min period were sampled every 469 ms to produce a
256-point Radix 2 FFT without overlap. A Hanning window was
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Figure 1
An example of the three heart rate variability
components examined during each phase of the
menstrual cycle. LF, low frequency (0.041–0.15 Hz);
HF, high frequency (0.15–0.80 Hz); TP, total power
(0–1.0 Hz).






























applied to each power spectrum to minimise spectral leakage and
the following three frequency components examined for each
power spectrum (Fig. 1): (1) low frequency (LF, 0.041–0.15 Hz)
which reflects sympathetic and parasympathetic modulation; (2)
high frequency (HF, 0.15–0.80 Hz), which reflects para-
sympathetic modulation; and (3) total power (TP, 0–1.0 Hz),
which reflects primarily parasympathetic modulation (Pagani et
al. 1986; Task Force of the European Society of Cardiology and
the North American Society of Pacing and Electrophysiology,
1996). Each component was expressed in absolute units
(ms2 Hz_1) and where possible in normalised units (nu).
Normalised units were calculated by dividing the absolute power
of a given component by the TP minus frequencies below
0.041 Hz (Pagani et al. 1986). The LH/HF ratio was also
determined for each spectrum and, along with the measures of
HRV in nu, was used as an index of sympathovagal balance
(Pagani et al. 1986).
All data are presented as means ± S.E.M. Statistical comparisons
were made using the statistical package SPSS (SPSS Inc. Chicago,
IL, USA). Significant differences for HRV, HR and hormone
levels during the menstrual cycle were determined by one-way
repeated measures ANOVA and Fisher’s least significant
difference test (Howell, 1992). Data not fitting the assumptions
of these parametric parameters were analysed using Friedman’sx2 test and Nemenyi’s procedure (Hatch & Lazaraton, 1991).
Relationships between variables were determined by Spearman’s
rank-order correlation (r). Only correlation coefficients > ±0.5
were considered. P < 0.05 was taken as statistically significant.
RESULTS
Cyclic variations in all endogenous female sex hormones
were evident during the menstrual cycle and included
significantly greater oestrogen (17b-oestradiol) and LH
levels at ovulation, and significantly greater oestrogen
(17b-oestradiol) and progesterone levels at the luteal phase
(Fig. 2).
Despite these normal cyclic hormonal variations and a
significantly greater resting HR at ovulation (menses,
62.6 ± 2.5 beats min_1; ovulation, 66.3 ± 2.3 beats min_1;
luteal, 62.8 ± 1.8 beats min_1; P < 0.05), no measure of HRV
was significantly different between menstrual cycle phases
(Fig. 3).
Correlations between oestrogen (17b-oestradiol) levels
and absolute measures of HRV (LF, HF and TP) at
ovulation were observed (Fig. 4). No other significant
correlations were identified.
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Figure 2
Plasma concentrations of follicle-stimulating
hormone (FSH) and luteinising hormone (LH)
(A), and 17b-oestradiol (Oest) and progesterone
(Prog) (B) during the three main phases of the
menstrual cycle. Values shown are mean + S.E.M.
* P < 0.05, ** P < 0.01, *** P < 0.001, significantly
different to menses.































Significantly greater HRV and vagal activity in the
follicular phase (Sato et al. 1995; Saeki et al. 1997) and
greater sympathetic activity during the luteal phase (Guasti
et al. 1999; Yildirir et al. 2002) compared with other phases
of the menstrual cycle have been reported. The enhanced
vagal activity at ovulation has been attributed to the
increased endogenous oestrogen levels, while the reduced
HRV and greater sympathetic activity during the luteal
phase has been attributed to the greater endogenous
progesterone levels (Sato et al. 1995; Saeki et al. 1997;
Yildirir et al. 2002). However, such fluctuations in HRV
during the menstrual cycle could reflect the interaction of
several endogenous sex hormones since FSH and LH peak
around ovulation and oestrogen peaks again around
day 21 (luteal) of the menstrual cycle. In the current study
we have demonstrated similar HRV regardless of menstrual
cycle phase and endogenous female sex hormone levels, in
agreement with previous studies (Kondo et al. 1989;
Yildirir et al. 2002). Further, no significant correlations
between HRV and FSH or LH were evident in the current
study, suggesting that FSH and LH were not associated
with modification of cardiac autonomic control as
measured by HRV. In the current study we examined HRV
only at times of low and high sex hormone levels during
the menstrual cycle as it was anticipated that during these
times the possible interaction between the levels of
endogenous female sex hormones and HRV would be
more apparent. However, the lack of HRV fluctuations
during the menstrual cycle in the current study may be
associated with the timing of HRV recordings as previous
studies have reported increased vagal activity (lower LF nu
and LF/HF ratio, greater HF nu) only during the follicular
phase (days 3–11) compared with other phases of the
menstrual cycle (Sato et al. 1995; Saeki et al. 1997).
Collectively, the results of the current and previous studies
indicate that vagal activity may be greater during the early
follicular phase of the menstrual cycle and subsequently
lower at other phases of the menstrual cycle, possibly due
to the influences of increasing levels of FSH and LH
(ovulation) and progesterone (ovulation and luteal phases).
In the current study, significant correlations between
oestrogen levels and all absolute measures of HRV at
ovulation were demonstrated reflecting a positive
relationship between oestrogen and vagal activity as only
the parasympathetic nervous system regulates HR control
at all frequencies (Akselrod et al. 1985). This significant
relationship between oestrogen levels and HRV in the
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Figure 3
Absolute (A) and normalised (B) components of
HRV during the three main phases of the
menstrual cycle. LF, low frequency; HF, high
frequency; TP, total power. Values shown are
mean + S.E.M.






























current study, and reports of oestrogen-induced
enhancement of vagal activity (Saleh & Connell, 2000;
Saleh et al. 2001) and reduction of sympathetic activity
(Ettinger et al. 1998; Mercuro et al. 2000) suggest that vagal
dominance during the early follicular phase of the
menstrual cycle may result from increasing levels of
endogenous oestrogen. Subsequent increases in endogenous
levels of FSH, LH and progesterone may then inhibit the
influence of oestrogen on cardiac autonomic control as
demonstrated by the similar HRV during the ovulation
and luteal phases in the current and previous studies
(Kondo et al. 1989; Saeki et al. 1997). Previous reports of
greater sympathetic activity during peak progesterone
levels of the luteal phase (Sato et al. 1995; Guasti et al. 1999;
Yildirir et al. 2002) and increased HR and lower HRV in
post-menopausal women following combined oestrogen/
progesterone hormone replacement therapy (HRT) (Christ
et al. 2002) provide further support of the proposed vagal
inhibitory nature of progesterone. The possible existence
and extent of the inhibitory influences of FSH and LH on
cardiac autonomic control is presently unknown. Further
studies are needed to explore the possible vagal inhibitory
actions of FSH and LH and whether there is a period
during the menstrual cycle of reduced cardioprotection
and increased risk of cardiac arrhythmias/events (Kleiger et
al. 1987; Tsuji et al. 1996).
To date, the reported differences in HRV between the sexes
have been equivocal (Bigger et al. 1995; Gregoire et al.
1996; Huikuri et al. 1996; Yeragani et al. 1997; Sinnreich et
al. 1998), with several studies reporting greater para-
sympathetic activity for females compared to males
(Gregoire et al. 1996; Huikuri et al. 1996). Reported
male/female differences in HRV could be the result of
comparing HRV in females at a time of the menstrual cycle
when HRV is enhanced due to ovarian hormonal
influences, that is, during the early follicular phase (Sato et
al. 1995; Saeki et al. 1997). To our knowledge, studies
examining male/female differences in HRV have not
considered the menstrual cycle phase at which HRV
recordings were obtained for females. Therefore, it is
suggested that HRV measurements in females, for
comparisons between females and between the sexes, be
conducted at a similar phase of the menstrual cycle to
account for the effects of endogenous female sex
hormones. For practical reasons it is suggested that HRV
recordings be obtained at times other than the early
follicular phase (days 5–12) of the menstrual cycle when
vagal activity is enhanced compared to other phases of the
cycle (Sato et al. 1995; Saeki et al. 1997).
In the present study we have demonstrated no
synchronistic changes in HRV with endogenous female sex
hormone levels at the three main phases of the menstrual
cycle. Possible inhibitory influences of FSH, LH and
progesterone on oestrogen could account for the lack of
oestrogen-induced increased HRV and vagal activity during
the menstrual cycle in the current study. Correlations
between oestrogen and HRV at ovulation in the current
study provided further support of the reported cardio-
protective effects of oestrogen. Possible male/female
differences in HRV may result from recording HRV at a
time of minimal female endogenous sex hormone
interaction (i.e. early follicular phase only).
Sex hormone influences on heart rate controlExp Physiol 88.3 445
Figure 4
Correlation between absolute measures of HRV and
17b-oestradiol (Oest) at ovulation. LF, low
frequency; HF, high frequency; TP, total power.
* P < 0.05, a P < 0.054.
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